Search results
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 15 hours agoNovo Nordisk and Eli Lilly have long dominated the rapidly growing weight loss drug market, but...
Insider Sale: Segment President Marc Prieur Sells 3,200 Shares of AptarGroup Inc (ATR)
GuruFocus.com via Yahoo Finance· 15 minutes agoAptarGroup Inc (NYSE:ATR), a company specializing in the design and manufacturing of a broad range...
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 1 hour agoThe authorisation is the approval to market a drug in EU’s member states. The withdrawal was due to...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 38 minutes agoGeneva, Switzerland, May 8, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug& ...
Eli Lilly Alzheimer’s drug gets FDA panel date after approval delay
The Hill via AOL· 15 hours agoAn outside panel of advisers to the Food and Drug Administration (FDA) will meet next month to...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 28 minutes ago...Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, today announced...
Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares
Investor's Business Daily· 11 hours agoVertex stock advanced Tuesday as analysts debated the company's pain drug, VX-548, with one saying...
Mark Cuban Cost Plus Drug Company Teams Up with RxLink to Bring Pharmacy Cost Transparency to...
WKBN 27 Youngstown· 18 hours agoToday, RxLink, a firm founded with the same commitment to price transparency in prescription medicine as Mark Cuban Cost Plus Drug Company, PBC (Cost Plus ...
Hygrovest increases Net Asset Value per share by 23% to A$0.1355 in April
Proactive Investors· 45 minutes ago...due to a 50% increase in the Enterprise Value to Net Revenue Multiple (EV/NRM) used by HGV when...
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 2 days agoThe earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 companies,...
